Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates

Adaptive Biotechnologies (ADPT) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of$ 0.30. This compares to loss of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 26.67%. A quarter ago, it was expected that this life-sciences research company would post a loss of$ 0.32 per share when it actually produced a loss of $0.26, delivering a surprise of 18.75%.Over the last four qu ...